lipitor
Well, it seems that
Pfizer is ready to move on from that embarrassing
"Dr. Jarvik is not actually licensed to practice medicine" kerfuffle back in February. The company pulled its Lipitor spots after Congress became very interested in whether or not the ads were misleading the public into believing that Dr. Jarvik was qualified to offer medical advice — and that he was
really rowing that boat. Now, the
Wall Street Journal has a tantalizing preview of the new
"Dr. Jarvik Free" Lipitor ad. The spot features a regular person named John — a heart attack survivor who urges you to learn from his example and be more proactive about controlling your cholesterol (with Lipitor, damn it! Lipitor!).
More »
departures
Weary of all the "fake rowing" controversy, Pfizer has canned Dr. Robert Jarvik (the inventor of the Jarvik artificial heart) as a spokesperson for their blockbuster cholesterol drug,
Lipitor.
More »
badvertising
Congress has been asking some tough questions while wearing their serious faces about why Dr. Robert Jarvik (inventor of the Jarvik artificial heart) is shilling
Lipitor when he's not actually licensed to practice medicine.
More »
big pharma
Dr. Robert Jarvik is the inventor of the Jarvik artificial heart, right? You know that because he's the pitch-man for Lipitor, a heavily advertised cholesterol drug. Have you ever stopped to ask yourself why inventing an artificial heart qualifies the man to pitch a drug?
More »
drugs
Pfizer is in panic mode about its rapid decline in
Lipitor sales—in the last 18 months, it has dropped from 40% of the market for cholesterol-lowering drugs to 30%, and likely to drop further—so it's launched a big media-blitz
to convince people not to switch to simvastatin, the generic version of its name-brand competitor, Zocor. Zocor was more expensive than Lipitor, so Pfizer had nothing to worry about for years—but then Zocor lost its patent protection last year, and now doctors are switching patients from Lipitor over to Zocor's generic twin to save money.
More »